Citation Tools

Download PDFPDF
Clinical trials
Effects of enzyme replacement therapy on the cardiomyopathy of Anderson–Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa

Download to a citation manager

Cite this article as:
Hughes DA, Elliott PM, Shah J, et al
Effects of enzyme replacement therapy on the cardiomyopathy of Anderson–Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa